A syngeneic anti-idiotype monoclonal antibody (MAb) (CM-I I) directed against an anti-carcinoembryonic antigen (CEA) murine MAb (NP-4) was evaluated as a second antibody (SA) to promote the rapid clearance of radiolabeled NP-4 from the blood. Initial studies confirmed that CM-I I IgG removed l3Il-NP
Pharmacokinetic study of radiolabeled anti-colorectal carcinoma monoclonal antibodies in tumor-bearing nude mice
✍ Scribed by Jean-Yves Douillard; Jean-François Chatal; Jean Claude Saccavini; Chantal Curtet; Mireille Kremer; Patrick Peuvrel; Hilary Koprowski
- Publisher
- Springer
- Year
- 1985
- Tongue
- English
- Weight
- 822 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Nude mice carrying human squamous-cell carcinoma xenografts were given i.v. injections of radiolabelled monoclonal antibodies (Mas). MAb E 48, which reacts with squamouscell carcinomas, was labelled with i3'l, while a second control MAb of similar immunoglobulin subclass was labelled with lZ5l. Both
## Abstract Three different monoclonal antibodies (mabs) directed against conformation‐dependent protein determinants in carcinoembryonic antigen (CEA) were evaluated for tumorimmunolocalization of CEA‐containing human tumors grown in nude mice. The antibodies were of high affinity and of the IgG~1
## RESULTS. The relative uptake of G250 in NU-12 tumors was very high at low protein doses (125% injected dose/g [%ID/g]), but decreased at higher doses, suggesting
## BACKGROUND. The immunoglobulin G 1 (IgG 1 ) monoclonal